Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Intraosseous infusion devices Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The intraosseous infusion devices market has witnessed robust growth in recent years. It is projected to increase from $3.39 billion in 2025 to $3.61 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.6%. This historical growth can be ascribed to several factors including the rising occurrence of trauma and cardiac emergencies, the imperative for swift vascular access within hospitals, the increasing adoption of manual IO devices, the expansion of emergency medical services (EMS), and the early application of intraosseous needles in pediatric care.
The market size for intraosseous infusion devices is anticipated to show substantial growth in the upcoming years. It is projected to increase to $4.71 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.8%. This expansion during the forecast period can be attributed to several factors, including the increasing adoption of automated IO devices, the integration of IO systems into hospital emergency protocols, the wider use of IO in ambulatory surgical centers, heightened investment in training and simulation tools, and the development of multi-site intraosseous access solutions. Significant trends expected in the forecast period include rapid emergency vascular access, adaptation of devices for both pediatric and adult patients, the rise of battery-powered and reusable drivers, the preference for single-use and disposable devices, and the incorporation of training and simulation.
Download A Free Sample Report For Comprehensive Market Insights:
#Intraosseous infusion devices Market Demand Drivers Creating New Revenue Opportunities
The rising frequency of trauma and emergency events is projected to stimulate the growth of the intraosseous infusion devices market in the future. These incidents encompass medical situations that demand immediate or urgent attention due to severe injuries, acute illnesses, or life-threatening conditions requiring rapid assessment and intervention. The incidence of such cases is escalating, primarily driven by an increase in road traffic accidents, which are themselves fueled by higher vehicle density and high-speed travel, leading to more critical injuries and emergency hospital admissions. Intraosseous infusion devices provide swift and reliable access to the bloodstream when traditional intravenous access is difficult in trauma or shock scenarios, ensuring the rapid delivery of fluids and essential medications, thereby supporting timely and effective emergency care. For example, in September 2025, according to the National Health Service, a UK-based government health agency, total accident and emergency attendances reached 27.4 million in 2024–25, marking a 4.0 percent increase compared with 2023–24. Consequently, the growing occurrence of trauma and emergency cases is a significant factor boosting the expansion of the intraosseous infusion devices market. The increasing volume of hospital admissions is anticipated to drive the expansion of the intraosseous infusion devices market moving forward. Hospital admissions signify the formal acceptance of patients into medical facilities for inpatient care and treatment. This upward trend in admissions is predominantly influenced by the aging population, as elderly individuals frequently necessitate more medical interventions and have higher rates of chronic conditions that require hospitalization. Elevated hospital admissions enhance the demand for intraosseous infusion devices, as these tools offer quick vascular access during emergency situations and critical care contexts when conventional intravenous access proves challenging. For instance, in January 2025, data from the American Hospital Association, a US-based national organization representing hospitals and healthcare networks, indicated that total hospital admissions in the United States rose from 33,679,935 in 2022 to 34,426,650 in 2023, reflecting an increase of 746,715 admissions. Therefore, the growth in hospital admissions is a key impetus for the intraosseous infusion devices market.
Intraosseous infusion devices Market Segment Outlook: Which Categories Are Expanding The Fastest?
The intraosseous infusion devices market covered in this report is segmented –
1) By Product: Bone Injection Gun (B.I.G), First Access For Shock And Trauma 1 (FAST1), Easy Intraosseous (EZ-IO), First Access For Shock And Trauma Responder (FASTR), Intraosseous (IO) Needles, Other Products
2) By Technology: Manual, Automatic
3) By Route Of Administration: Sternum, Distal And Proximal Tibia, Distal Femur, Calcaneus, Head Of Humerus
4) By End User: Emergency Medical Services (EMS), Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers
Subsegments:
1) By Bone Injection Gun (B.I.G): Manual Activation, Spring Loaded Mechanism, Single Use Device, Adult Use Variant
2) By First Access For Shock And Trauma 1 (FAST1): Sternal Access Device, Single Use System, Rapid Vascular Access, Emergency Use Configuration
3) By Easy Intraosseous (EZ-IO): Battery Powered Device, Multiple Needle Sizes, Reusable Driver System, Emergency And Hospital Use
4) By First Access For Shock And Trauma Responder (FASTR): Sternal Insertion System, Prehospital Emergency Use, Single Use Configuration, Rapid Deployment Design
5) By Intraosseous (IO) Needles: Manual Insertion Needles, Powered Insertion Compatible, Pediatric Size Needles, Adult Size Needles
6) By Other Products: Disposable Intraosseous Devices, Training And Simulation Devices, Accessory And Stabilization Kits, Custom Intraosseous Systems
Intraosseous infusion devices Market Trends Driving Strategic Industry Expansion
Major companies operating in the intraosseous infusion devices market are concentrating on developing advanced systems, such as rapid vascular access devices, to facilitate faster and more reliable vascular access during life-threatening emergencies. A rapid vascular access device is a medical instrument designed for swift entry into the circulatory system to administer fluids, medications, or blood products in emergency and critical care scenarios. It is particularly valuable when traditional intravenous access methods are challenging, time-consuming, or impractical. For example, in October 2024, BD, a US-based medical technology company, unveiled the new BD Intraosseous Vascular Access System, an enhanced intraosseous access solution engineered to establish vascular access within seconds for critical care situations. This system incorporates improved needle control, rapid insertion capability, and a user-friendly design to support clinicians in high-pressure environments, thereby boosting procedural efficiency and improving patient outcomes in emergency and acute care settings.
Intraosseous infusion devices Market Key Companies And Competitive Benchmarking
Major companies operating in the intraosseous infusion devices market are Cardinal Health Inc., Medline Industries Inc., Becton Dickinson and Company (BD), B Braun Melsungen AG, ZOLL Medical Corporation, Teleflex Incorporated, Cook Medical LLC, Shandong Weigao Group Co Ltd, Vygon SA, Argon Medical Devices Inc., Life Assist, Istem Medikal, SAM Medical Products, Implox Pty Ltd., BIOPSYBELL S R L (BPB Medica), Medax SRL, Troge Medical GmbH, Taizhou Kindly Medical Devices Co Ltd, PAVmed Inc., and Pyng Medical Corporation
Access The Complete Intraosseous infusion devices Market Report:
Intraosseous infusion devices Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the intraosseous infusion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intraosseous infusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.